Inhibition of human CPA1 peptide degradation activity at 5 to 500 nM using neurotensin peptide as substrate preincubated for 2 hrs followed by substra...

Basic Information

ID: ALA4413980

Type: Binding

Description: Inhibition of human CPA1 peptide degradation activity at 5 to 500 nM using neurotensin peptide as substrate preincubated for 2 hrs followed by substrate addition and measured up to 7 hrs by MALDI-TOF/TOF spectrometry

Format: BAO_0000357

Organism: Homo sapiens

Target: Carboxypeptidase A1(ALA2088)

Document: ALA4411328

Inhibition of human CPA1 peptide degradation activity at 5 to 500 nM using neurotensin peptide as substrate preincubated for 2 hrs followed by substrate addition and measured up to 7 hrs by MALDI-TOF/TOF spectrometry: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4413980

Inhibition

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
490.49	2.51	2.51

Parent Molecular Weight

ALogP

Polar Surface Area

490.49

2.51

Inhibition of human CPA1 peptide degradation activity at 5 to 500 nM using neurotensin peptide as substrate preincubated for 2 hrs followed by substra...

Basic Information

Activity Charts

Compound Summary